Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis
This study found increased cyclooxygenase-2 and matrix metalloproteinase-2 expression in adenomyosis and endometrial polyps, with higher microvessel density in adenomyosis and polyps during the secretory phase.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (33)
- Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle via openalex
- Cyclooxygenase-2 expression in endometrial polyps during menopause via openalex
- Dating the Endometrial Biopsy via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis via openalex
- Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium via openalex
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance via openalex
- Estrogen biosynthesis in human uterine adenomyosis via openalex
- Expression of aromatase cytochrome P450 in eutopic endometrium and its application as a diagnostic test for endometriosis via openalex
- High frequency of endometrial polyps in endometriosis via openalex
- Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis via openalex
- Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis via openalex
- Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells via openalex
- Stromal vascularization in the endometrium during adenomyosis via openalex
- Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice via openalex
- Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp via openalex
- W2085680573 via openalex
- W2071525349 via openalex
- W2098730279 via openalex
- W2100025529 via openalex
- W2047289419 via openalex
- W2111226394 via openalex
- W1995469282 via openalex
- W2127558096 via openalex
- W1985844039 via openalex
- W1685016018 via openalex
- W1547464524 via openalex
- W2170134994 via openalex
- W2045700530 via openalex
- W2319962899 via openalex
- W2028701802 via openalex
Cited by (39)
- Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
- Is Adenomyosis Associated with Systemic Vascular Complications? 2025
- Adenomyosis’ association with low progesterone yet increased interleukin-6, vascular endothelial growth factor and cyclooxygenase-2 2025
- Imaging and molecular features of adenomyosis after menopause 2024
- Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium 2024
- Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP, MMP14) in Eutopic and Ectopic Endometrium and in Serum and Endocervical Mucus of Endometriosis 2023
- Exosomes: potential diagnostic markers and drug carriers for adenomyosis 2023
- Endometrial Inflammation and Impaired Spontaneous Decidualization: Insights into the Pathogenesis of Adenomyosis 2023
- Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review 2023
- Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review 2022
- Insights on Adenomyosis Development 2022
- Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis 2022
- Immunometabolic profiling of cervicovaginal lavages identifies key signatures associated with adenomyosis 2022
- Increased Angiogenesis and Lymphangiogenesis in Adenomyosis Visualized by Multiplex Immunohistochemistry 2022
- Celecoxib reduces inflammation and angiogenesis in mice with adenomyosis 2021
- Immunological changes associated with adenomyosis: a systematic review 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review 2019
- Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review) 2019
- Current facts constituting an understanding of the nature of adenomyosis 2018
- Expression of Inflammatory and Neurogenic Mediators in Adenomyosis 2016
- Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis 2016
- Current and Future Medical Treatment of Adenomyosis 2016
- Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis 2015
- The Endometrium in Adenomyosis 2015
- Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells 2015
- Ekspresja IL-1 i TNF- w mięśniakach macicy i tkance otaczającej u kobiet w różnym wieku 2013
- Estradiol and tamoxifen enhance invasion of endometrial stromal cells in a three-dimensional coculture model of adenomyosis 2013
- Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide 2013
- Estradiol and tamoxifen enhance invasion of endometrial stromal cells in a three-dimensional coculture model of adenomyosis 2013
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- Endometriosis and Angiogenic Factors 2012
- The endometrium in adenomyosis 2012
- Relationship between adenomyosis and uterine polyps 2011
- Coexistence of adenomyosis in women operated for benign gynecological diseases 2011
- Mechanisms of normal and abnormal endometrial bleeding 2011
- Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors 2010
- Expression of COX-2 in intestinal endometriosis to: Tokyol C, et al. Int J Gynecol Pathol 2009;28:148-56 2010
- Adenomyosis: new knowledge is generating new treatment strategies 2009
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:06:07.402396+00:00